The global organ on a chip market was valued at US$ 157.06 million in 2024 and is expected to reach US$ 2,238.28 million by ...

Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted full approval for VITRAKVI® (larotrectinib), a first-in-class TRK inhibitor for the treatment of adult and pediatric ...

Kanazawa University and colleagues have developed a promising new approach to cancer treatment. By using tiny, naturally ...

With a clear focus on evolving community needs, PRIME Hospital has significantly expanded its clinical capabilities, introducing a series of specialised departments designed to provide advanced ...

Learn the benefits and limitations of a full-body MRI scan. Discover if it's right for cancer detection and when healthcare ...

Cancer drugs that inhibit CDK7 rapidly shut down pathways responsible for cell proliferation within minutes. For organs to develop, grow, and regenerate, cells must divide and multiply, a process ...

Imagine a super-charged immune cell that can launch a focused attack on stubborn solid tumors -- a smart fighter that destroys cancer cells for days without tiring. Biomedical engineers have made this ...